SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-004915
Filing Date
2015-10-20
Accepted
2015-10-20 13:28:51
Documents
11
Period of Report
2015-08-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 405537
2 ex31-1.htm EX-31.1 7756
3 ex31-2.htm EX-31.2 7821
4 ex32-1.htm EX-32.1 4785
5 ex32-2.htm EX-32.2 4457
  Complete submission text file 0001493152-15-004915.txt   2113417

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE obmp-20150831.xml EX-101.INS 265331
7 XBRL SCHEMA FILE obmp-20150831.xsd EX-101.SCH 23977
8 XBRL CALCULATION FILE obmp-20150831_cal.xml EX-101.CAL 31640
9 XBRL DEFINITION FILE obmp-20150831_def.xml EX-101.DEF 109972
10 XBRL LABEL FILE obmp-20150831_lab.xml EX-101.LAB 164388
11 XBRL PRESENTATION FILE obmp-20150831_pre.xml EX-101.PRE 151800
Mailing Address 330 CLEMATIS STREET SUITE 217 WEST PALM BEACH FL 33401
Business Address 330 CLEMATIS STREET SUITE 217 WEST PALM BEACH FL 33401 561-514-0936
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 151166010
SIC: 7310 Services-Advertising